Cargando…
Clinical Efficacy of Oral Ganciclovir for Prophylaxis and Treatment of Recurrent Herpes Simplex Keratitis
BACKGROUND: Herpes simplex keratitis (HSK) caused by herpes simplex virus 1 (HSV-1), which has high recurrent rate and incidence of severe vision loss, is the leading cause of infectious blindness in the world. The aim was to explore the clinical efficacy of oral ganciclovir (GCV) in the prevention...
Autores principales: | Wang, Xin, Wang, Linnong, Wu, Nianlang, Ma, Xinjun, Xu, Jianjiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837818/ https://www.ncbi.nlm.nih.gov/pubmed/25563312 http://dx.doi.org/10.4103/0366-6999.147808 |
Ejemplares similares
-
Clinical Efficacy of Oral Ganciclovir for Prophylaxis and Treatment of Recurrent Herpes Simplex Keratitis: Corrigendum
Publicado: (2015) -
Corrigendum: Clinical Efficacy of Oral Ganciclovir for Prophylaxis and Treatment of Recurrent Herpes Simplex Keratitis
Publicado: (2016) -
Immunological Aspects of Acute and Recurrent Herpes Simplex Keratitis
por: Rolinski, Jacek, et al.
Publicado: (2014) -
Clinical efficacy of oral and topical acyclovir in herpes simplex virus stromal necrotizing keratitis
por: Dutt, Surabhi, et al.
Publicado: (2016) -
Alopecia Following Oral Acyclovir for the Treatment of Herpes Simplex Keratitis
por: Sharma, Ashok, et al.
Publicado: (2014)